BPC-157 was placed on the FDA's Category 2 bulk drug substance list, meaning it cannot be compounded by commercial pharmaceutical companies
Newsletter Sign-Up Lux Complimentary Consultation New patients receive $75 off your first treatment!
Bacteriostatic Water Each vial is reconstituted separately
Documentation and order review Availability, product identity, listed quantity, price, packaging, transport terms, storage information, and any supporting analytical documents are confirmed for the actual item or accepted order

The Promising Findings GHK-Cu has the most robust human evidence, particularly for topical skincare applications BPC-157 shows impressive results in animal studies for wound healing, collagen production, and tissue repair Peptides generally have favorable safety profiles in the studies that exist The mechanisms make biological sense: peptides do play real roles in healing The Limitations Most studies on BPC-157 and TB-500 are animal-based, not human There are no standardized dosing protocols for most injectable peptides Long-term safety data in humans is limited Many peptides are not FDA-approved for cosmetic or surgical recovery purposes Quality control varies widely between compounding pharmacies Important: Many injectable peptides are classified as research compounds and are not approved for human use outside of clinical trials
Ive noticed better joints and skin within 2 weeks